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Recently, we identified a particular T-cell subset in the pe-
ripheral blood of normal individuals that lack CD7 expres-
sion. In thi~ study we determined. the forti~m of C~~)7-T ~ells 
in the penpheral blood and skm 0 jatlents with vanous 
inflammatory skin diseases. We foun that skin-infiltrating 
lymphocytes isolated from different benign and malignant 
skin lesions (n = 20) contain a high portion of CD7- helper 
T cells, whereas the number of CD7- T cells in the periph-
eral blood was not altered compared to healthy controls. Cell 
activation in vitro did not induce CD7 expression in negative 
T cells but increased CD7 expression in CD7 -positive cells. 
Thus, lack of CD7 expression seems to be a stable character-
C D7 is a 40-kilodalton (kD) glycoprotein expressed on the surface of peripheral blood T cells and thymo-cytes early during T-cell ontogeny [1]. Therefore, CD7 expression is a useful marker for the identifica-tion ofT-cell malignancies. Although the functional 
role of the CD7 molecule remains to be elucidated, recent studies 
indicate that CD7 may be involved in signal transduction and/or 
may function as an adhesion molecule during T-cell activation [2,3]. 
CD7- T cells have been found in a number of pathologic condi-
tions, suggesting that absence of this antigen may have important 
pathophysiologic consequences. Absence of CD7 expression on T 
cells was reported to be associated with severe combined immuno-
deficiency l4]. Furthermore, in contrast to the majority of T-cell 
malignancies, cutaneous T-cell lymphoma (CTCL) predominantly 
lacks CD7 expression. This phenomenon is reported to be helpful in 
differentiating a malignant lymphoma from reactive cutaneous in-
filtrates [5,6]. Furthermore, leukemic T cells in CTCL, character-
ized as structurally distinctive T lymphoid cells with a highly con-
voluted nucleus (Sezary cells), do not express CD7 [7]. With the 
exception of this antigen, however, Sezary cells express the same 
marker spectrum as normal mature helper T cells. 
Recently, we identified a subpopulation of CD7- T cells in the 
peripheral blood of normal donors [8]. Northern blot analysis re-
vealed regulation of CD7 expression at the mRNA level. The ma-
jority of circulating CD7- T cells are of the CD4+ "memory" 
phenotype. Thus, absence of CD7 on T cells in vivo seems to be a 
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istic in a major subset of skin-infiltrating lymphocytes. Dur-
ing long-term culture of CD7- helper T-cell clones derived 
from a psoriasis skin lesion, no phenotypic change in the 
CD7 phenotype could be monitored by sequential flow-
cytometric analyses. No CD7 mRNA could be detected by 
Northern blot analysis, indicating transcriptional regulation 
of CD7 expression. The results show that CD7- T cells 
accumulate in certain inflammatory skin lesions without al-
teration of the circulating CD7- population. These cells may 
be identical to or derived from cor T cells of the peripheral 
blood. Key words: CD7- T cells/skin injlammation/cutaneous 
lymphoma.] Invest DermatoI102:328-332, 1994 
stable phenotype in a subset of normal peripheral blood T cells. In 
this study we determined the portion of CD7- T cells in the periph-
eral blood and in the skin of patients with various inflammatory skin 
diseases. Interestingly, skin-infiltrating lymphocytes (SILs) derived 
from a variety of benign and malignant skin diseases predominantly 
consist of T cells that lack CD7 antigen expression. In contrast, the 
population of CD7- T cells in peripheral blood is not altered. The 
results implicate a specific physiologic function of CD7- helper T 
cells during inflammatory reactions of the skin. 
MATERIALS AND METHODS 
Cell Isolation and Culture SILs were isolated from various inflamma-
tory skin lesions (psoriasis vulgaris [n = 7]. atopic dermatitis [n = 5], cuta-
neous T-cell lymphoma [n = 4], lichen planus [n = 2], pityriasis rubra pilaris 
[n = 1], pityriasis lichenoides et varioliformis acuta [n = 1]) as previously 
described [9]. 
Briefly, a punch biopsy was obtained from each patient, subcutaneous 
adipose tissue was removed, and residual biopsy was devided into several 
pieces and cultered in RPMI 1640 medium (GIBCO, Berlin, FRG) contain-
ing 10% h",at-inactivated human pooled male serum (Sigma, Munich, FRG), 
2 mM L-glutamine, penicillin 100 IU Iml, streptomycin 100 ttg/ml, recom-
binant human interleukin-2 (IL-2; 100 U/ml, Euro Cetus Corporation, 
Amsterdam, The Netherlands) , 20 Gy irradiated pooled peripheral blood 
mononuclear cells (PBMCs) as filler cells, and either 5 ttg/ml phytohemag-
glutinin (PHA; Biochrom, Berlin, FRG) or 2.5 nglml anti-CD3 antibody 
(OKT3; Ortho Pharmaceutical, Neckargemiind, FRG) at 37°C, 5% CO2 , 
During 7 -12 d of culture, mononuclear cells migrated out of tissue. Cells 
were harvested and phenotyped by immunofluorescence analysis. 
PBMCs were isolated from heparinized blood (50 IU Iml) of 39 healthy 
donors and 31 patients with inflammatory dermatoses (psoriasis vulgaris 
[n = 7] and atopic dermatitis [n = 24]) using standard Ficoll-Isopaque gra-
dient centrifugation. 
T-cell-enriched populations were purified from PBMCs by passage 
through a nylon-wool column (Wako Chemicals, Neuss, FRG). The con-
tamination with CD14+ monocytes and CD19+ B cells was less than 1%. 
CD7+ and CD7- cells were separated by magnetic activated cell sorting 
(MACS; Miltenyi Biotec GmbH, Bergisch Gladbach, FRG) [10]. Briefly, 
cells were labeled with monoclonal anti-CD7 antibody (3Al; Biozol, Ech-
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Figure 1. Phenotypic identification of a CD4+CD7- T-cell subset in the 
peripheral blood of patients with psoriasis vulgaris (n = 7; open bar), atopic 
dermatitis (n = 24; striped bar), and age-matched healthy controls (n = 39; 
solid bar). Two-color immunofluorescence analysis was performed simulta-
neously using FITC- and PE-conjugated monoclonal antibodies, as de-
scribed in Materials a~ld Methods. Data are expressed as mean percentage 
CD4+CD7- cells ± SD. 
ing, FRG) for 30 min at 4" C, washed in phosphate-buffered saline (PBS) 
containing 1 % bovine serum albumin (BSA) and incubated with biotinylated 
goat anti -mouse immunoglobulin (Ig)M + IgG F(ab'l,-fragments (Dian-
ova, Hamburg, FRG). Subsequently, the cells were incubated with fluores-
cein isothiocyanate (FITC)- conjugated avidin (Becton Dickinson) and with 
colloidal superparamagnetic microbeads with functional biotin groups (Mil-
tenyi Biotec GmbH). Labeled (CD7+) cells were separated from unlabeled 
(CD7- ) cells by passage through a steelwool column placed into a magnetic 
field of 0.6 Tesla. Under these conditions, CD7- cells passed the column 
whereas CD7+ cells adhered to the steelwool. CD7+ cells could be recovered 
by removal of the column from the magnetic field and elution with PBS. 
Homogeneity of purified CD7- cells «3% positive cells) and CD7+ cells 
(> 97% positive cells) was monitored by immunofluorescence analysis. 
Immunophenotyping Flow-cytometric analyses were performed by 
twO- and three-color immunofluorescence using FITC-, phycoerythrin 
(PE)-, and peridinium chlorophyll protein reagent (PerCP)-conjugated 
monoclonal antibodies (MoAb). For indirect immunofluorescence, cells 
were labeled with unconjugated MoAb followed by PE-conjugated rabbit 
anti-mouse immunoglobulin F(ab'l, fragments (Dakopatts, Hamburg, 
FRG). 
Fluorescence was excited at 488 nm with a 15-m W Argon laser on a 
fluorescence-activated cell sorter (FACS) (FACScan; Becton Dickinson, 
Mountain View, CAl . Simultaneous forward and side-scatter analyses were 
used to gate the lymphocyte population. Fluorescence intensities of 5000 
cells/probe were determined. 
The following antibodies were used: T-cell receptor (TCR)-l (alpha/ 
beta-TCR), Leu-5 (CD2), Leu-4 (CD3), Leu-3a (CD4), Leu-2a (CD8), 
Leu-II (CD16), Leu-18 (CD45RA), Leu-7 (CD57), IL-2-Rec (CD25), all 
from Becton Dickinson; UCHLl (CD45RO), from Dakopatts, Glostrup, 
Denmark; intercellular adhesion molecule-l (ICAM-l; CD54), from Dian-
ova, Hamburg, FRG; CD27, CD28, from Janssen Biochimica, Briiggen-
Bracht, FRG; 3Al (CD7) from Biozol, Eching, FRG; HECA-452 (cutane-
ous lymphocyte antigen CLA, kindly provided by Dr. Louis Picker, 
Southwestern Medical Center, Dallas, Texas). 
Cloning Skin-infiltrating lymphocytes isolated from a psoriasis skin le-
sion were cloned in microtest plates (Nunc, Roskilde, Denmark) at 0.2 - 0.3 
cells/well in RPM! 1640 medium containing 10% human serum, IL-2 (100 
U /ml), OKT3 (2.5 ng/ml) , and pooled PBMCs. Growing cells were propa-
gated for more than 4 months by subculturing every 3-4 d. 
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Table I. Phenotypic Analyses of SILs· 
Patient Diagnosis CD4+ CD8+ CD4+CD7+ CD4+CD7-
1 Psoriasis 79 6 2 77 
2 Psoriasis 83 8 58 25 
3 Psoriasis 89 9 45 44 
4 Psoriasis 65 27 52 13 
5 Psoriasis 91 9 69 22 
6 Psoriasis 90 12 53 37 
7 Psoriasis 92 7 56 36 
8 AD 94 <2 68 26 
9 AD 78 17 65 13 
10 AD 87 20 35 52 
11 AD 74 24 54 20 
12 AD 97 3 53 44 
13 CTCL 75 15 50 25 
14 CTCL 78 11 67 11 
15 CTCL 92 4 84 8 
16 CTCL 25 75 19 6 
17 Lichen planus 71 14 45 26 
18 Lichen planus 35 63 19 16 
19 PRpb 89 6 75 14 
20 PLA' 26 46 14 12 
• Data arc expressed as percent positive cd 1s. 
h Pityriasis rubra pilaris. 
, Pityriasis Iichenoides acura. 
Cell Activation Purified normal CD7- and CD7+ cells, expanded SILs, 
and propagated skin-derived T-cell clones were incubated in RPM! 1640 
medium, 10% human serum, in the presence of 5 J-Lg/ml PHA (Biochrom), 
400 ng/ml ionomycin (Calbiochem, Frankfurt, FRG), 10 ng/ml 12-0-
tetradecanoyl-phorbol-13-acetate (TPA) (Sigma) or combinations of these 
for different periods of time (6 h, 12 h, 24 h, 48 h, 72 h, 96 h) . Subse-
quently, 5 X 105 cells were harvested and analyzed for CD4 and CD7 sur-
face antigen expression by flowcytometry. 
Northern Blot Analysis Total cellular RNA was isolated from cells by 
lysis in a solution containing 4 mM guanidinium isothiocyanate, 50 mM 
Tris, pH 7.6, 10 mM ethylenediamine tetraacetic acid (EDTA) , 10 mM 
beta-mercaptoethanol, 2% sodIUm dodecyl sulfate (SDS), and sedimentation 
through a cushIOn of 5.7 M CsCl, 100 mM EDTA, pH 7.5, by centrifuga-
tIOn at 200,000 X g for 12 h. RNA was extracted with chloroform and 
butanol, and precipitated with ethanol. RNA was transfered by blotting 
techniques onto Hybond N membranes (Amersham Buchler, Braunsch-
:-veig, FRG). For hybridiza tions, the following cloned DNA fragments were 
Isolated from vector DNA sequences before radioactive labeling: 1.7 kilo-
base (kb) CD7 cDNA [11], 1.2 kb Pst! fragment of pGAP dehydrogenase 
[12]. 
Table II. Surface Phenotype of Individual T-Cell Clones" 
Clone 
Antigen Ps03 Pso13 Pso30 Ps033 
TCR-1 >98 >98 >98 >98 
CD2 >98 >98 >98 >98 
CD3 >98 >98 >98 >98 
CD4 >98 >98 >98 >98 
CD7 <2 <2 97 >98 
CD8 <2 <2 <2 <2 
CD16 <2 <2 <2 <2 
CD27 <2 <2 <2 <2 
CD28 54 39 53 31 
CD45RO >98 >98 >98 >98 
CD45RA <2 <2 <2 <2 
CD54 4 10 6 <2 
CD57 4 <2 <2 4 
Leu-8 <2 <2 <2 <2 
HECA-452 58 27 27 15 
, T-cell clones were established froll1 a psoriasis skin lesion an.d propagated in the 
presence of IL-2. Surface marker phenotypes were established by flow cytometry. The 
values represent percent positive cells. 
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Figure 2. Analysis of CD7 regulation in PH A 
CDr (A) and CD7+ (B) T-cell clones de-
rived from a psoriatic skin lesion. Clones 
were stimulated with PHA (5 Itg/ml) i" 
vitro and expression of CD7 was monitored 
by flow cytometry 12 and 72 h after stimu- B 
lation. For control reasons, cells of each 
clone were cultured in medium and subse-
quently analyzed by flow cytometry. Data 
are expressed as single histograms and show 
expression of CD7 as red flllorescence. Medium 
PHA 
Oh 
Statistical Analyses Differences between data sets were assessed using 
the Mann-Whitney U-test. Data are expressed as mean ± standard deviation 
(SD). Coefficient of correlation was determined by linear regression. 
RESULTS 
Identification of CD7- Helper T Cells in the Peripheral 
Blood of Normal Humans and Patients with Inflammatory 
Skin Diseases CD4+CD7- T cells represent 9 ± 3.4% of circu-
lating PBMCs in normal healthy donors (unmatched, n = 39; age 
range, 1-86 years). Interestingly, the number of circulating 
CD4+CDr T cells correlates with the age of the donors (r = 0.62; 
p < 0.01). Three-color immunofluorescence analysis showed that 
CLA antigen is expressed on an average of 58% of CD4+CD7- T 
cells (range, 42 - 76%, n = 10), but only on an average of 9% of 
CD4+CD7+ T cells (range, 6-12%, n = 10). Furthermore, we de-
termined the number of circulating T cells with the CD4+CD7-
phenotype in benign inflammatory skin diseases by immunofluo-
rescence analyses (Fig 1). By mean, 4.1 ± 1.1 % of circulating 
PBMCs from psoriasis patients (n = 7; mean age, 25.3 years; range, 
21-31 years) and 4.5 ± 2.4% of PBMCs from atopic dermatitis 
patients (n = 24; mean age, 24.5 year~; range, 20-29 years) express 
the CD4+CD7- phenotype. No difference 111 the number of 
CD4+CD7- T cells between age-matched healthy controls (n = 
25; mean age, 26.5 years; range, 20-30 years) compared to patients 
with inflammatory dermatoses was recorded. 
Isolation and Immunophenotyping ofSILs Lymphocyte cul-
tures were generated from punch biopsies (n = 20) of various in-
fl ammatory skin lesions. After 8 - 12 d of culture, cells that had 
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12 h 72 h 
migrated out of tissue were harvested and analyzed by flow cytome-
try. SILs contained a high portion of CD7- T cells (range, 8 - 75%) 
in comparison to those of the peripheral blood (p < 0.01). All cells 
expanded expressed the CD3 antigen and the majority of CD7-
SILs expressed the CD4+ helper T cell phenotype (Table I). The 
predominance of CD7- cells in propagated SIL cultures is unlikely 
to be a culture artefact because cultivation of PBMCs under identi-
cal conditions revealed the same portion of CD7- and CD7+ T cells 
as monitored in peripheral blood (not shown) . W e established three 
CDr T-cell clones derived from SILs of a psoriatic skin lesion. For 
control reasons two CD7+ clones from the same biopsy were gener-
ated and propagated under identical culture conditions. During a 
culture period of more than 4 months, all clones retained their 
pattern of CD7 antigen expression. Furthermore, immunopheno-
typic analyses of various T-cell markers on propagated clones were 
performed. All of the CD7- clones expressed CD4 antigen and 
alpha/beta TCR to the same extent as CD7+ clones. No clones were 
observed that express CD45RA, whereas all clones were positive for 
CD45RO. All clones contained cells that expressed CLA antigen 
although the number of cells stained in each of the clones differed 
widely. Furthermore, all clones had a comparable high expression 
of major histocompatibility complex (MHC) class II antigens and 
the p55-IL-2 receptor (not shown). In summary, all clones showed 
the same pattern of surface antigen expression except for CD7 
(Table II). 
Modulation of CD7 Antigen Expression In Vitro To analyze 
whether CD7 expression can be induced in CD7- T cells, SILs were 
stimulated with PHA or Io/TPA itlvitro and analyzed by flow-cyto-
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Figure 3. Total cellular RNA (15 J.lg) of CD7- T-cell clones (lanes 1, 3, 4) 
and of CD7+ T-cell clones (lanes 2, 5) isolated from a psoriasis skin lesion 
were hybridized to the 1.7-kb CD7 cDNA probe (A) . For control reasons, 
the Northern blot was rehybridized to the 1.2-kb Pst! fragment of pGAPD 
DNA (B). 
metry. These agents were not capable of inducing CD7 expression 
in CD7- cells, whereas CD7 antigen expression increased in CD7+ 
cells. For comparison, CD4 expression on both CD7+ and CD7-
T cells, respectively, decreased to the same degree after stimulation 
in vitro. 
Furthermore, CD7- and CD7+ T-cell clones derived from psori-
atic SILs were stimulated using PHA or IojTPA ill vitro. As ex-
pected, CD4 expression decreased within 48 h in all clones tested . 
Moreover, CD7 expression increased on CD7+ clones, whereas 
CD7- T-cell clones did not express detectable CD7 antigen even 
after stimulation (Fig 2). On the other hand, CD4 expression de-
creased in all clones after incubation with ionomycin plus TPA, 
w ith minimal expression 48 h after stimulation. The CD7+ and 
CD7- subpopulations from the peripheral blood, respectively, 
showed the same response after stimulation with PHA or IojTPA 
(not shown). 
Analysis of CD7 mRNA Transcripts CD7- T-cell clones iso-
lated from a psoriatic skin lesion and propagated hI vitro in the 
presence of IL-2 were subjected to Northern blot analysis for CD7 
mRNA expression. As shown in Fig 3, no CD7-specific mRNA 
transcript could be detected whereas cells of the CD7+ clones ex-
press the 1.7-kb CD7 mRNA, as expected. 
DISCUSSION 
Recently, we characterized a small subset of peripheral T cells that 
lack expression of the CD7 antigen [8]. These cells represent a 
physiologic subpopulation of normal human T cells from periph-
eral blood. The majority of circulating CD7- T cells express the 
CD4+CD45RO+CD45RA- memory phenotype of helper T cells. 
Molecular analyses have revealed a regulation of CD7 expression at 
the level of mRNA transcription. These data suggest that the lack of 
CD7 characterizes a particular subset of memory helper cells in the 
peripheral blood of normal individuals. 
The mononuclear cell infiltrates of most inflammatory skin dis-
eases have been found to be predominantly CD4+ helper T cells 
[13]. Moreover, the majority oflesional helper T cells in inflamma-
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tory dermatoses, e.g., atopic dermatitis , psoriasis, nummular derma-
titis, and pityriasis rosea, were reported to express the memory 
helper phenotype [14]. In addition to benign cutaneous infiltrates, 
the predominance of the CD4+ memory helper phenotype has been 
demonstrated in skin lesions of CTCL. A high number of lesional T 
cells in different types of CTCL were shown to la.ck CD7 expres-
sion, in contrast to the peripheral blood [5,6]. This phenomenon has 
been reported to be helpful in differentiating a malignant lym-
phoma from reactive cutaneous infiltrates. Furthermore, nonex-
pression of CD7 is a classical feature of leukemic Sezary cells in 
CTCL [7]. However, recent immunohistologic studies indicated 
that lack of CD7 expression on T cells is not confined to malignant 
lymphoid infiltrates but can be also found in benign inflammatory 
skin lesions "I" [15 ,16]. In addition, a high number of CD7- T cells 
was found in normal epidermal and dermal skin [17,18]. To eluci-
date whether skin-associated T lymphocytes are of CD7- pheno-
type, we analyzed SILs derived from various inflammatory skin 
diseases in.comparison to peripheral blood lymphocytes. Unexpect-
edly, SILs Isolated from different benign and malignant skin lesions 
contained a high portion of CD7- memory helper T cells, whereas 
the portIOn of these cells in the peripheral blood was not altered 
compared to those of normal healthy controls. Cell activation in 
vitro upregulated CD7 expression in positive cells but did not induce 
CD7 expression in negative T cells. These results confirm our re-
cent findings obtained with fresh T cells from normal healthy 
donors [8] . Thus, absence of CD7 seems to be a stable phenotype in a 
major subset of SILs. Analysis of long-term cultured CD7- helper 
T-cell clones denved from psoriatic skin lesions revealed no pheno-
typic change in both CD7- and CD7+ clones with respect to CD7 
expression. Northern blot analysis of psoriatic CD7- clones indi-
cated absence of CD7 at the mRNA level. Our data presented here 
s~pport ~vidences for a separate lineage in the late phase of T-cell 
differentiation. We speculate that the subset of T cells found in 
normal skin and certain inflammatory skin lesions may be identical 
to or derived from CD7- T cells of the peripheral blood, which may 
display skin tropism. Consistent with recent reports, we conclude 
that CD7 expression on cutaneous infiltrates is not a good marker to 
differentiate benign inflammatory reactions from malignant infil-
trates [15]. 
The physiologic role of CD7 remains to be determined. CD7 
MoAb crosslinking was reported to induce changes in intracellnlar 
Ca2+, as well as sti~1U l ation ofT-cell proliferation [19]. Therefore, 
CD7~ has been discussed to play a role in modulating T -cell-
adheSive lllteractlOns. However, the ligand for CD7 remains to be 
~dentified. ~)n .tl~e other hand, absence of CD7 expression on T cells 
111 norma~ mdlvlduals characterizes a particular subset of memory 
cells and IS not a marker for T-cell activation. We monitored that 
abse,:ce of CD7 is as~ociated with a weak proliferation in response 
to mltogens and a.ntl-CD3 MoAb, in contrast to CD7+ cells [8]. 
Recent result~ llldicate that CD7- T cells may show a more pro-
nounced prohferauve response when stimulated via the CD2 path-
way [20] . Thus, absence of CD7 on T cells might correspond to a 
subset o.f ~emory cells with a different activation pathway. Recent 
s~udles I~dlcate th~t the majority of T cells infi ltrating cutaneous 
sites of mflammauon express a carbohydrate ligand (CLA) for 
ELAM-1, which appears to act as a skin lymphocyte homing recep-
tor [21]. In additIOn to cutaneous infiltrates CLA was reported to be 
expressed on a minor subpopulation of circu lating memory cells in 
normal individuals [22]. Interestingly, our studies demonstrate that 
a n~ajor subset of normal circulating CD7- T cells express CLA 
antigens. We suggest that functional analyses of this particular 
T-cell subset might generate more information about the physio-
logiC role of CD7- T cells in the human skin. Moreover, the exact 
identification of different stages in late-phase T-cell maturation 
t Ralfkiaer E: Reactivity of the workshop panel of CD7 antibodies in 
benign cutaneous conditions and known and suspected cutaneous T-cell 
lymphomas (abstr). Tissue Antigens 33:49, 1989. 
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might help to clarify whether CD7- cells may represent the physio-
logic counterpart of malignant Sezary cells. 
We t!,al,k Drs. Aruffo atld Seed (Department oJMolecular Biology, Massachusetts 
Getleral Hospital, Boston) and Dr. Malldel (It,stitute de Chimie Biologique, Stras-
bourg, France) Jor SlJpplying recombinant plasmid probes. 
Tl'is work was SIIpported by the Deutsche ForschutlgsgemeitlSchaft DFG (Gratlt 
Re 690/3-1). 
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